利用超快乳腺磁共振成像预测新辅助治疗后的病理反应 - Suppr | 超能文献

Ultrafast Breast MRI to Predict Pathologic Response after Neoadjuvant Therapy.

作者信息

Lee Cindy S, Moy Linda

机构信息

From the Department of Radiology, New York University Langone Medical Center, 550 1st Ave, New York, NY 10016.

出版信息

Radiology. 2022 Dec;305(3):575-577. doi: 10.1148/radiol.221511. Epub 2022 Jul 26.

DOI:10.1148/radiol.221511

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Ultrafast Breast MRI to Predict Pathologic Response after Neoadjuvant Therapy.

Radiology. 2022 Dec;305(3):575-577. doi: 10.1148/radiol.221511. Epub 2022 Jul 26.

2

Prospective Evaluation of Ultrafast Breast MRI for Predicting Pathologic Response after Neoadjuvant Therapies.

Radiology. 2022 Dec;305(3):565-574. doi: 10.1148/radiol.220389. Epub 2022 Jul 26.

3

The assessment of breast cancer response to neoadjuvant chemotherapy: comparison of magnetic resonance imaging and 18F-fluorodeoxyglucose positron emission tomography.

Acta Radiol. 2011 Feb 1;52(1):21-8. doi: 10.1258/ar.2010.100142.

4

Ultrafast dynamic contrast-enhanced breast MRI: association with pathologic complete response in neoadjuvant treatment of breast cancer.

Eur Radiol. 2022 Jul;32(7):4823-4833. doi: 10.1007/s00330-021-08530-4. Epub 2022 Jan 22.

5

MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer.

Breast Cancer Res. 2018 Apr 18;20(1):34. doi: 10.1186/s13058-018-0950-x.

6

Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.

Breast Cancer Res Treat. 2019 Jan;173(2):455-463. doi: 10.1007/s10549-018-4990-9. Epub 2018 Oct 16.

7

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR).

Breast Cancer Res. 2019 Jan 31;21(1):19. doi: 10.1186/s13058-018-1091-y.

8

The use of a second core needle biopsy to predict response to neoadjuvant chemotherapy in breast cancer patients, especially in the HER2-positive population.

Surgery. 2020 Dec;168(6):1115-1121. doi: 10.1016/j.surg.2020.06.045. Epub 2020 Sep 8.

9

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer.

Clin Cancer Res. 2008 Oct 15;14(20):6580-9. doi: 10.1158/1078-0432.CCR-07-4310.

10

Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?

Clin Breast Cancer. 2020 Feb;20(1):e82-e88. doi: 10.1016/j.clbc.2019.05.015. Epub 2019 Jun 6.

引用本文的文献

1

Superior performance in classification of breast cancer molecular subtype and histological factors by radiomics based on ultrafast MRI over standard MRI: evidence from a prospective study.

Radiol Med. 2025 Mar;130(3):368-380. doi: 10.1007/s11547-025-01956-6. Epub 2025 Jan 25.